Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083. (2023)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lana.2022.100416
PubMed Identifier: 36844011
Publication URI: http://europepmc.org/abstract/MED/36844011
Type: Journal Article/Review
Volume: 18
Parent Publication: Lancet regional health. Americas
ISSN: 2667-193X